Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ): Price and Financial Metrics

JAZZ POWR Grades

• Value is the dimension where JAZZ ranks best; there it ranks ahead of 97.6% of US stocks.
• The strongest trend for JAZZ is in Stability, which has been heading up over the past 177 days.
• JAZZ ranks lowest in Momentum; there it ranks in the 32nd percentile.

JAZZ Stock Summary

• JAZZ PHARMACEUTICALS PLC's market capitalization of $8,947,464,430 is ahead of 83.31% of US-listed equities.
• Over the past twelve months, JAZZ has reported earnings growth of -157.18%, putting it ahead of merely 10.01% of US stocks in our set.
• The volatility of JAZZ PHARMACEUTICALS PLC's share price is greater than that of just 8.82% US stocks with at least 200 days of trading history.
• If you're looking for stocks that are quantitatively similar to JAZZ PHARMACEUTICALS PLC, a group of peers worth examining would be REKR, GAN, INPX, EGLX, and TRUE.
• JAZZ's SEC filings can be seen here. And to visit JAZZ PHARMACEUTICALS PLC's official web site, go to www.jazzpharma.com.

JAZZ Valuation Summary

• In comparison to the median Healthcare stock, JAZZ's price/sales ratio is 48.94% lower, now standing at 2.4.
• Over the past 192 months, JAZZ's price/sales ratio has gone down 6.5.

Below are key valuation metrics over time for JAZZ.

JAZZ Growth Metrics

Its 2 year revenue growth rate is now at 50.82%.
• The 4 year net income to common stockholders growth rate now stands at -31.5%.
• The 3 year net cashflow from operations growth rate now stands at -16.25%.

JAZZ's revenue has moved up $1,422,221,000 over the prior 33 months.

The table below shows JAZZ's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	3,583.982	1,107.761	-18.687
2022-06-30	3,481.445	963.83	-51.872
2022-03-31	3,300.378	702.489	-449.853
2021-12-31	3,094.238	778.507	-329.668
2021-09-30	2,863.024	787.023	-160.903
2021-06-30	2,625.797	770.852	40.164

JAZZ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• JAZZ has a Quality Grade of C, ranking ahead of 58.49% of graded US stocks.
• JAZZ's asset turnover comes in at 0.32 -- ranking 143rd of 680 Pharmaceutical Products stocks.
• REGN, AGLE, and NTLA are the stocks whose asset turnover ratios are most correlated with JAZZ.

The table below shows JAZZ's key quality metrics over time.